Why AngioDynamics Stock Popped, Then Dropped Today

AngioDynamics' big Q4 earnings beat wasn't as impressive as it first seemed.Tuesday started off well for AngioDynamics (ANGO -10.18%), maker of such medical devices as the NanoKnife tool for "electrocuting" cancer, as well as multiple devices for treating peripheral vascular disease. In the morning, AngioDynamics reported stronger-than-expected Q4 2025 sales and earnings, with sales of $80.2 million and an adjusted loss of $0.03 per share (instead of the $0.12-per-share forecast).By the end of the day, howe ...